To include your compound in the COVID-19 Resource Center, submit it here.
Top-line data from the open-label, U.S. Phase III ASTRAL-5 trial in 104 patients with chronic HCV genotype 1-6 and HIV co-infection
Sign in to your BioCentury account to access your content.
Get a two-week free trial subscription to BioCentury